yannick allanore

Université Paris Descartes

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (9)

Vanessa Smith

Ghent University Hospital

Manuel Silvério-António

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes

Sonia Pezet

Institut de Myologie

Jérôme Avouac

Université de Paris Faculté de Santé

Britta Maurer

University Hospital of Zurich

Robert Sandler

University of Sheffield

UNITED KINGDOM

Christopher Denton

University College London

UNITED KINGDOM

Corrado Campochiaro

Vita-Salute San Raffaele University

Bruno LUCAS

CNRS Délégation Paris B

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

yannick allanore

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (9)

Vanessa Smith

Manuel Silvério-António

Sonia Pezet

Jérôme Avouac

Britta Maurer

Robert Sandler

Christopher Denton

Corrado Campochiaro

Bruno LUCAS

Make your next move.

yannick allanore

Research Interests

Explore related searches

Contact this professor

Articles (19)

Validation of the definition of rheumatoid arthritis flare based on SDAI and CDAI in clinical practice in two French independent cohorts.

Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

Effects of B cell depletion by CD19‐targeted CAR‐T cells in a murine model of systemic sclerosis

Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis

Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine

Should complete B-cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.

Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment.

The phenotype of mixed connective tissue disease patients having associated interstitial lung disease.

Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort.

IL-2-related regulatory CD4 T-cell deficiency leads to the development of lung fibrosis and vascular remodeling.

Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

Immunogenicity of Rituximab biosimilar GP2013 in chronic inflammatory rheumatic disorders in daily clinical practice.

Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis.

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.

Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study.

Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis.

An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years.

Collaborators (9)

Vanessa Smith

Manuel Silvério-António

Sonia Pezet

Jérôme Avouac

Britta Maurer

Robert Sandler

Christopher Denton

Corrado Campochiaro

Bruno LUCAS

Make your next move.